New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
09:25 EDTSNTI, SNTI, SRNE, SRNE, SPEX, SPEX, CDXC, CDXC, CBMX, CBMX, SSET, SSET, OPK, OPK, CGIX, CGIXRedChip Companies to hold a virtual conference
RedChip Emerging Growth Showcase is being held on January 22-23 with webcasted presentations to begin on January 23 at 9:30 am. Webcast Link
News For OPK;CGIX;SNTI;SRNE;SPEX;CDXC;CBMX;SSET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
06:07 EDTSPEXSpherix comments on pending settlement between Cisco, Rockstar Consortium
Subscribe for More Information
November 18, 2014
09:06 EDTCDXCChromaDex initiated with a Buy at Sidoti
Subscribe for More Information
November 12, 2014
07:22 EDTCGIXAssociation of Molecular Pathology is holding annual meeting
2014 Annual Meeting of AMP is being held in National Harbor, Maryland on November 12-15.
November 11, 2014
07:56 EDTCGIXCancer Genetics receives second patent for FHACT
Cancer Genetics announced that it has received a second U.S. patent covering its proprietary FISH-based HPV-Associated Cancer Test, or FHACT, for cervical cancer detection in patients. FHACT is designed to assess change across four biomarkers indicating HPV-associated pre-cancers and cancers. Critically, FHACT can help prevent unnecessary colposcopies and cervical biopsies, reducing costs and complications associated with these invasive procedures.
November 10, 2014
08:39 EDTOPKOPKO Health reports publication of validation of 4Kscore test in prostate cancer
OPKO Health announced the online publication of a multi-institutional, prospective study of the 4Kscore Test in the journal European Urology. The results of the study demonstrated that the 4Kscore provides a patient with accurate and personalized information about their risk of having Gleason Score 7 prostate cancer, making it a useful tool for selecting men who have significant disease and are most likely to benefit from a prostate biopsy, the company said.
07:58 EDTCGIXCancer Genetics reports adjusted Q3 EPS (41c), consensus (48c)
Reports Q3 revenue $3.22M, consensus $3.18M.
November 7, 2014
08:29 EDTOPKOPKO Health reports Q3 EPS (11c), consensus (7c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use